Renewal: Pannexin-1 signaling in abdominal aortic aneurysms
更新:腹主动脉瘤中的 Pannexin-1 信号传导
基本信息
- 批准号:10734519
- 负责人:
- 金额:$ 72.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-07-09 至 2028-06-30
- 项目状态:未结题
- 来源:
- 关键词:Abdominal Aortic AneurysmAgingAneurysmAnimalsAortaAortic AneurysmAortic RuptureAortitisApoptosisApoptoticBindingBlood CirculationCell DeathCell surfaceCellsChronicChronic DiseaseClinicalCoagulation ProcessCollagenCommunicationCystineDataDisease ProgressionElastasesElastinElderlyEndothelial CellsEnzymesEquilibriumFeedbackFibrinFunctional disorderGelatinase AGeneticGlutamate TransporterGoalsGrowthHumanImmuneImpairmentIn VitroInflammagingInflammationInflammatoryIronKnockout MiceLeucocytic infiltrateLipid PeroxidationLipid PeroxidesMacrophageMediatingMediatorMedicalMethodsModelingMolecularMusNaturePathogenesisPathway interactionsPatientsPhagocytesPhenotypePhosphorylationPhysiologicalPlayPopulationPrevalencePreventionProcessProductionProtein SReceptor Protein-Tyrosine KinasesRegulationResistanceResolutionRoleSamplingSignal TransductionSmall Interfering RNASmooth Muscle MyocytesSpironolactoneSudden DeathTestingThinnessThrombusTissuesTunica AdventitiaVascular Endothelial CellVascular remodelingbiobankclinical translationcytokineerastinexperimental studyextracellularin vivoinhibitorinnovationinsightknock-downmortalitymouse modelneutrophilnovelpreventreceptorsystemic inflammatory responsetranscriptomics
项目摘要
PROJECT SUMMARY
Abdominal aortic aneurysms (AAA) formation and subsequent aortic rupture can lead to sudden death and is a
significant clinical problem with no currently known medical treatments available. The hallmarks of patient AAA
include thrombus formation and cell death mechanisms such as apoptosis and neutrophil extracellular traps
(NETs). The clearance of dead cell debris is mediated via the process of efferocytosis, by which apoptotic
tissue is recognized for engulfment by professional phagocytes (e.g., macrophages) and non-professional
phagocytes (e.g., endothelial cells; ECs), and remains to be elucidated in the pathogenesis of AAA. Thus, our
hypothesis focuses on the dysregulation of inflammation-resolution pathways that lead to to defective
efferocytosis and promote chronic aortic tissue inflammation and vascular remodeling. Our recent study has
demonstrated a critical role orchestrated by EC-dependent pannexin-1 (Panx1) channels in causing aortic
inflammation and AAA formation. The scientific premise of this proposal focuses on the dysregulation of EC-
mediated efferocytosis causing an imbalance of inflammation-resolution via Panx1 activation in AAA
progression. Therefore, the central hypothesis in this proposal is that EC efferocytosis is dysregulated due to
cleavage of MerTK, a cell surface tyrosine kinase receptor that recognizes apoptotic cells, leading to
accumulation of dead cell debris and thrombus formation. Second, our mechanistic studies will dissect the
dynamic communication between ECs and macrophages, involving defective EC-mediated efferocytosis
leading to excessive iron-mediated cell death (ferroptosis) in macrophages, that collectively feedbacks to
cause Panx1 activation and an chronic inflammatory loop. Our supportive data demonstrates that resolution of
aortic inflammation is associated with increased EC-dependent MerTK expression and efferocytosis of
neutrophils. Furthermore, defective EC-mediated efferocytosis exacerbates ferroptosis in macrophages (via
SLC7A11 and Nrf2-signaling) that feedbacks to cause EC-Panx1 activation and eATP release. Collectively, our
results suggest that dysregulation of EC-mediated efferocytosis and macrophage-dependent ferroptosis
creates a break in the inflammation-resolution process during AAA formation and aortic rupture. We will
delineate the proposed studies using the murine elastase-treatment AAA and our innovative aortic rupture
model, as well as by analysis of human AAA tissue from our biorepository. Using novel inducible cell-specific
genetic knockout mice such as Cdh5Cre-ERT2/MerTKfl/fl, MerTKCR (cleavage-resistant), and Cx3CR1Cre-
ERT2/SLC7A11fl/fl mice, we will delineate the previously unknown mechanisms of dysregulated efferocytosis and
ferroptosis in activation of Panx1 channels during AAA formation. Our studies will provide novel insight into
mechanisms of molecular signaling interactions between ECs and macrophages to define the inflammatory
loop between efferocytosis/ferroptosis/Panx1 for the treatment of AAAs and prevention of aortic rupture.
项目摘要
腹主动脉瘤(AAA)形成和随后的主动脉破裂会导致猝死,是一个
重大的临床问题,目前没有已知的医疗治疗。病人AAA的标志
包括血栓形成和细胞死亡机制,例如凋亡和中性粒细胞外陷阱
(网)。死细胞碎片的清除是通过凋亡的过程介导的,凋亡的过程
组织被专业的吞噬细胞(例如巨噬细胞)和非专业的吞噬者认可
吞噬细胞(例如,内皮细胞; EC),在AAA的发病机理中尚待阐明。因此,我们的
假设着重于炎症 - 解决途径的失调,导致有缺陷
肿瘤病并促进慢性主动脉组织炎症和血管重塑。我们最近的研究有
表现出由EC依赖性Pannexin-1(Panx1)渠道策划的关键作用在引起主动脉
炎症和AAA形成。该提案的科学前提重点是EC-的失调
通过AAA中的PANX1激活导致炎症分辨率失衡的介导的肿瘤病
进展。因此,该提议中的核心假设是,EC的肿瘤病因
MERTK的切割,MERTK是一种识别凋亡细胞的细胞表面酪氨酸激酶受体,导致
死细胞碎屑和血栓形成的积累。其次,我们的机械研究将剖析
EC和巨噬细胞之间的动态通信,涉及EC介导的肿瘤有缺陷
导致巨噬细胞中铁介导的细胞死亡过多(铁凋亡),共同反馈到
引起PANX1激活和慢性炎症环。我们的支持数据表明了解决
主动脉炎症与EC依赖性MERTK表达和肿瘤的增加有关
中性粒细胞。此外,巨噬细胞中的EC介导的衰减有缺陷加剧了铁凋亡(通过
SLC7A11和NRF2信号)反馈会导致EC-PANX1激活和EATP释放。总体而言,我们的
结果表明,EC介导的胞吐作用和巨噬细胞依赖性的铁肿瘤的失调
在AAA形成和主动脉破裂期间,在炎症解决过程中产生了突破。我们将
使用鼠弹性酶处理AAA和我们的创新主动脉破裂来描述拟议的研究
模型,以及通过对我们生物座的人类AAA组织的分析。使用新型诱导细胞特异性
遗传基因敲除小鼠,例如CDH5CRE-ERT2/MERTKFL/FL,MERTKCR(抗裂解)和CX3CR1CRE-
ERT2/SLC7A11FL/FL小鼠,我们将描述以前未知的失调肿瘤病和
AAA形成过程中PANX1通道激活中的铁凋亡。我们的研究将为您提供新颖的见解
ECS和巨噬细胞之间分子信号传导相互作用的机制来定义炎症
在治疗AAA和预防主动脉破裂的治疗的肿瘤/铁质细胞增多症/PANX1之间的循环。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Pharmacologic inhibition by spironolactone attenuates experimental abdominal aortic aneurysms.
- DOI:10.3389/fcvm.2023.1101389
- 发表时间:2023
- 期刊:
- 影响因子:3.6
- 作者:Ladd Z;Su G;Hartman J;Lu G;Hensley S;Upchurch GR Jr;Sharma AK
- 通讯作者:Sharma AK
Sex differences in specialized pro-resolving lipid mediators and their receptors in abdominal aortic aneurysms.
- DOI:10.1016/j.jvssci.2023.100107
- 发表时间:2023
- 期刊:
- 影响因子:0
- 作者:Filiberto, Amanda C;Leroy, Victoria;Ladd, Zachary;Su, Gang;Elder, Craig T;Pruitt, Eric Y;Lu, Guanyi;Hartman, Joseph;Zarrinpar, Ali;Garrett, Timothy J;Sharma, Ashish K;Upchurch, Gilbert R Jr
- 通讯作者:Upchurch, Gilbert R Jr
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ashish Kumar Sharma其他文献
Su1711 COLORECTAL ANASTOMOTIC LEAK: FACTORS AND EFFECTS.
- DOI:
10.1016/s0016-5085(24)04782-6 - 发表时间:
2024-05-18 - 期刊:
- 影响因子:
- 作者:
Saket Kumar;Ashish Kumar Sharma - 通讯作者:
Ashish Kumar Sharma
Optical properties of InI<sub>3</sub>: Density functional theory calculations and experimental results
- DOI:
10.1016/j.ssc.2022.115014 - 发表时间:
2022-12-15 - 期刊:
- 影响因子:
- 作者:
Ashish Kumar Sharma;Pradeep Kumar;Arvind Kumar;Kim Jungbog;Agnikumar G. Vedeshwar - 通讯作者:
Agnikumar G. Vedeshwar
Enhancing performance of operational utility-scale solar PV projects in India through re-powering: Potential and techno-economic assessment
- DOI:
10.1016/j.esd.2024.101574 - 发表时间:
2024-12-01 - 期刊:
- 影响因子:
- 作者:
Saurabh Motiwala;Sudarshan Kumar;Ashish Kumar Sharma;Ishan Purohit - 通讯作者:
Ishan Purohit
Ashish Kumar Sharma的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ashish Kumar Sharma', 18)}}的其他基金
Diversity Supplement: Novel specialized pro-resolving lipid mediators in resolution of aortic aneurysms and rupture
多样性补充:解决主动脉瘤和破裂的新型专业化脂质介质
- 批准号:
10239324 - 财政年份:2021
- 资助金额:
$ 72.22万 - 项目类别:
Novel specialized pro-resolving lipid mediators in resolution of aortic aneurysms and rupture
用于解决主动脉瘤和破裂的新型专业化脂质介质
- 批准号:
10645097 - 财政年份:2020
- 资助金额:
$ 72.22万 - 项目类别:
Novel specialized pro-resolving lipid mediators in resolution of aortic aneurysms and rupture
用于解决主动脉瘤和破裂的新型专业化脂质介质
- 批准号:
10200146 - 财政年份:2020
- 资助金额:
$ 72.22万 - 项目类别:
Novel specialized pro-resolving lipid mediators in resolution of aortic aneurysms and rupture
用于解决主动脉瘤和破裂的新型专业化脂质介质
- 批准号:
10032697 - 财政年份:2020
- 资助金额:
$ 72.22万 - 项目类别:
Novel specialized pro-resolving lipid mediators in resolution of aortic aneurysms and rupture
用于解决主动脉瘤和破裂的新型专业化脂质介质
- 批准号:
10449113 - 财政年份:2020
- 资助金额:
$ 72.22万 - 项目类别:
Novel specialized pro-resolving lipid mediators in resolution of aortic aneurysms and rupture
用于解决主动脉瘤和破裂的新型专业化脂质介质
- 批准号:
10620496 - 财政年份:2020
- 资助金额:
$ 72.22万 - 项目类别:
Novel specialized pro-resolving lipid mediators in resolution of aortic aneurysms and rupture
用于解决主动脉瘤和破裂的新型专业化脂质介质
- 批准号:
10440978 - 财政年份:2020
- 资助金额:
$ 72.22万 - 项目类别:
Pannexin-1 signaling in abdominal aortic aneurysms
腹主动脉瘤中的 Pannexin-1 信号传导
- 批准号:
10204789 - 财政年份:2018
- 资助金额:
$ 72.22万 - 项目类别:
Pannexin-1 signaling in abdominal aortic aneurysms
腹主动脉瘤中的 Pannexin-1 信号传导
- 批准号:
9973194 - 财政年份:2018
- 资助金额:
$ 72.22万 - 项目类别:
相似国自然基金
温度作用下CA砂浆非线性老化蠕变性能的多尺度研究
- 批准号:12302265
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于波动法的叠层橡胶隔震支座老化损伤原位检测及精确评估方法研究
- 批准号:52308322
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
微纳核壳结构填充体系构建及其对聚乳酸阻燃、抗老化、降解和循环的作用机制
- 批准号:52373051
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
东北黑土中农膜源微塑料冻融老化特征及其毒性效应
- 批准号:42377282
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
高层建筑外墙保温材料环境暴露自然老化后飞火点燃机理及模型研究
- 批准号:52376132
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Targeting smooth muscle cell BMAL1 as a new therapeutic strategy against restenosis
靶向平滑肌细胞 BMAL1 作为抗再狭窄的新治疗策略
- 批准号:
10561398 - 财政年份:2023
- 资助金额:
$ 72.22万 - 项目类别:
Imaging-based biomechanical assessment of abdominal aortic aneurysms for improved progression risk prediction
基于成像的腹主动脉瘤生物力学评估,以改善进展风险预测
- 批准号:
10481360 - 财政年份:2022
- 资助金额:
$ 72.22万 - 项目类别:
Role of cyclic nucleotide signaling in aortic aneurysm
环核苷酸信号传导在主动脉瘤中的作用
- 批准号:
10538778 - 财政年份:2022
- 资助金额:
$ 72.22万 - 项目类别:
Eliminating Ischemic Spinal Cord Injury and Paralysis after Aortic Aneurysm Surgery
消除主动脉瘤手术后的缺血性脊髓损伤和瘫痪
- 批准号:
10469194 - 财政年份:2022
- 资助金额:
$ 72.22万 - 项目类别:
Acquisition of timsTOF Pro for Complex Lipidomic Analyses
购买 timsTOF Pro 用于复杂脂质组学分析
- 批准号:
10413379 - 财政年份:2022
- 资助金额:
$ 72.22万 - 项目类别: